$1.840
+0.062 (+3.37%)At close
Technical Sentiment
Overall Consensus
Technical Analysis Consensus
Moving Average Consensus
Grace Therapeutics, Inc (GRCE) Moving Averages Convergence Divergence (MACD) indicator is -0.06, suggesting GRCE is Strong sell.
Grace Therapeutics, Inc (GRCE) 20-Day simple moving average is 1.90, while Grace Therapeutics, Inc (GRCE) share price is $—, making it Sell.
Grace Therapeutics, Inc (GRCE) 60-Day simple moving average is 2.06, while Grace Therapeutics, Inc (GRCE) share price is $—, making it Sell.
Technical Analysis for GRCE
AI Technical GRCEAs of 2026-11-02, the technical board for Grace Therapeutics, Inc (GRCE) reads strong sell: 1 indicators are flashing buy, 8 are indicating sell, and 4 are neutral. Price at $1.84 sits below the 10-day, 20-day, 60-day and 200-day moving averages and above the 5-day.
Momentum readings: RSI stands at 43.692, MACD stands at -0.0618 (Sell), Stochastic %K stands at 35.833, Stochastic %D stands at 36.111 and CCI stands at -81.61.
GRCE trades below the 60-day SMA (2.06) and below the 200-day SMA (2.77). Immediate resistance sits at Classic R1 2.05, then R2 2.24. Support sits at Classic S1 1.67, then S2 1.48.
Grace Therapeutics, Inc (GRCE) Support & Resistance Level
Grace Therapeutics, Inc (GRCE) Technical Indicators
2026-11-03
| Name | Value |
|---|---|
| RSI_14 | 43.692 |
| STOCHk_14_3_3 | 35.833 |
| STOCHd_14_3_3 | 36.111 |
| CCI_20 | -81.610 |
| AO_5_34 | -0.136 |
| MOM_10 | -0.080 |
| MACD_12_26_9 | -0.062 |
Grace Therapeutics, Inc (GRCE) Relative Strength Index (RSI_14) is 43.692, creating a Neutral signal.
Grace Therapeutics, Inc (GRCE) Stochastic %K is 35.833, creating a Neutral signal.
Grace Therapeutics, Inc (GRCE) Stochastic %D is 36.111, creating a Neutral signal.
Grace Therapeutics, Inc (GRCE) CCI_20 is -81.610, creating a Neutral signal.
Grace Therapeutics, Inc (GRCE) Awesome Oscillator (AO) is -0.136, creating a Sell signal.
Grace Therapeutics, Inc (GRCE) Momentum (MOM) is -0.080, creating a Sell signal.
Grace Therapeutics, Inc (GRCE) Moving Average Convergence Divergence (MACD) is -0.062, creating a Sell signal.
Grace Therapeutics, Inc (GRCE) Moving Average
2026-11-03
| Period | Simple | Signal |
|---|---|---|
| MA_5 | 1.818 | Buy |
| MA_10 | 1.866 | Sell |
| MA_20 | 1.904 | Sell |
| MA_60 | 2.060 | Sell |
| MA_200 | 2.772 | Sell |
| MA_250 | 2.890 | Sell |
Grace Therapeutics, Inc (GRCE) 5-Day simple moving average is 1.818, while Grace Therapeutics, Inc (GRCE) share price is $, making it a Buy.
Grace Therapeutics, Inc (GRCE) 10-Day simple moving average is 1.866, while Grace Therapeutics, Inc (GRCE) share price is $, making it a Sell.
Grace Therapeutics, Inc (GRCE) 20-Day simple moving average is 1.904, while Grace Therapeutics, Inc (GRCE) share price is $, making it a Sell.
Grace Therapeutics, Inc (GRCE) 60-Day simple moving average is 2.060, while Grace Therapeutics, Inc (GRCE) share price is $, making it a Sell.
Grace Therapeutics, Inc (GRCE) 200-Day simple moving average is 2.772, while Grace Therapeutics, Inc (GRCE) share price is $, making it a Sell.
Grace Therapeutics, Inc (GRCE) 250-Day simple moving average is 2.890, while Grace Therapeutics, Inc (GRCE) share price is $, making it a Sell.
Related articles
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.